首页|期刊导航|药物分析学报（英文）|Advancing drug safety and mitigating health concerns:High-resolution mass spectrometry in the levothyroxine case study

Advancing drug safety and mitigating health concerns:High-resolution mass spectrometry in the levothyroxine case study

Hana Chmelařová Maria Carmen Catapano Jean-Christophe Garrigues František Švec Lucie Nováková

药物分析学报（英文）2024，Vol.14Issue(9)：1361-1371,11.

药物分析学报（英文）2024，Vol.14Issue(9)：1361-1371,11.DOI:10.1016/j.jpha.2024.100970

Advancing drug safety and mitigating health concerns:High-resolution mass spectrometry in the levothyroxine case study

Hana Chmelařová ¹Maria Carmen Catapano ¹Jean-Christophe Garrigues ²František Švec ¹Lucie Nováková¹

作者信息

1. Department of Analytical Chemistry,Faculty of Pharmacy in Hradec Králové,Charles University,Akademika Heyrovského 1203,500 05,Hradec Králové,Czech Republic
2. Laboratoire SOFTMAT(IMRCP),Université de Toulouse,CNRS UMR 5623,Université Paul Sabatier,118 route de Narbonne,31062 Toulouse Cedex 9,France
折叠

摘要

关键词

Levothyroxine/Excipients/Impurities/UHPLC-DIA-HRMS/Drug safety

Key words

Levothyroxine/Excipients/Impurities/UHPLC-DIA-HRMS/Drug safety

引用本文复制引用

Hana Chmelařová,Maria Carmen Catapano,Jean-Christophe Garrigues,František Švec,Lucie Nováková..Advancing drug safety and mitigating health concerns:High-resolution mass spectrometry in the levothyroxine case study[J].药物分析学报（英文）,2024,14(9):1361-1371,11.

基金项目

This work was supported by the project EFSA-CDN(Project No.:CZ.02.01/0.0/0.0/16_019/0000841)co-funded by ERDF.The authors thank the French Association of Thyroid Diseases(AFMT)for providing the samples of levothyroxine formulations for this study. （Project No.:CZ.02.01/0.0/0.0/16_019/0000841）

药物分析学报（英文）

ISSN：2095-1779

访问量0

下载量0

段落导航